SCHEMBL801194

SCHEMBL801194

CC(C)(C)c1ccc([Si](c2ccc(-n3c4ccc(P(=O)(c5ccccc5)c5ccccc5)cc4c4cc(P(=O)(c5ccccc5)c5ccccc5)ccc43)cc2)(c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 10/20 0.37
▸ PPARA Q07869 3/20 0.37
▸ PTGES O14684 1/20 0.35
▸ NR1H4 Q96RI1 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ MAT2A P31153 1/20 0.34
▸ TEAD1 P28347 1/20 0.34
▸ TEAD4 Q15561 1/20 0.34
▸ TEAD2 Q15562 1/20 0.34
▸ TEAD3 Q99594 1/20 0.34
▸ MDM2 Q00987 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801597 0.98 PPARG (0.36) PPARGPPARAPTGESNR1H4NPSR1
SCHEMBL801164 0.93 PPARG (0.41) PPARGPPARAPTGESNR1H4NPSR1
SCHEMBL801335 0.90 PPARG (0.39) PPARGPPARAPTGESNR1H4NPSR1
SCHEMBL801300 0.90 NPSR1 (0.35) NPSR1MAPTKDM4EMEN1RAB9A
SCHEMBL801604 0.90 PPARG (0.38) PPARGPPARANR1H4NPSR1MDM2
SCHEMBL801600 0.89 PPARG (0.39) PPARGPPARAPTGESNR1H4NPSR1
SCHEMBL801163 0.88 NPSR1 (0.38) NPSR1MAPTKDM4EMEN1RAB9A
SCHEMBL801102 0.88 NPSR1 (0.34) NPSR1MAPTKDM4EMEN1RAB9A
SCHEMBL801432 0.88 NPSR1 (0.34) NPSR1MAPTKDM4EMEN1RAB9A
SCHEMBL801721 0.87 PPARG (0.42) PPARGPPARAPTGESNR1H4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 PPARG 1500/4885PPARA 1218/4885PTGES 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback